Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Bruker Corporation Announces Acquisition Of Field-Portable Platform For Fast And Universal Immunoassay-Detection Of Bacteria, Viruses And Toxins August 2, 2017 Intuitive Surgical Reports New Employee Option Grants For June 2017 June 8, 2017 Pfizer Turns to to Explore $2 Billion Sale of Certain Assets February 1, 2017
Bruker Corporation Announces Acquisition Of Field-Portable Platform For Fast And Universal Immunoassay-Detection Of Bacteria, Viruses And Toxins August 2, 2017
